Predictions
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
22.08.22
22.08.22
€10.00
22.08.23
22.08.23
-13.85%
23.08.22
23.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€29.94
20.10.21
20.10.21
€35.00
31.12.23
31.12.23
65.15%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year
Energy Recovery
Start price
Target price
Perf. (%)
€17.20
03.08.21
03.08.21
€20.00
03.08.22
03.08.22
24.07%
29.07.22
29.07.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.19
27.06.22
27.06.22
€1.00
27.06.23
27.06.23
26.17%
09.07.22
09.07.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Agile Therapeutics Inc.
Start price
Target price
Perf. (%)
€79.50
27.06.22
27.06.22
€100.00
27.06.23
27.06.23
40.88%
28.06.22
28.06.22
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Kezar Life Sciences
Start price
Target price
Perf. (%)
€10.20
16.11.21
16.11.21
€11.00
31.12.24
31.12.24
0.98%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.10
13.06.22
13.06.22
€1.00
13.06.23
13.06.23
7.81%
25.06.22
25.06.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Revlon Inc.
Start price
Target price
Perf. (%)
€1.06
13.06.22
13.06.22
€1.00
13.06.23
13.06.23
159.41%
14.06.22
14.06.22
Could be very worthwhile Investment >20% year
Capable Management
Good culture
Few uniques
Capital Bancorp Inc
Start price
Target price
Perf. (%)
€20.20
04.06.21
04.06.21
€20.00
04.06.22
04.06.22
5.94%
05.06.22
05.06.22
Could be worthwhile Investment >10% per year
Ingles Markets Inc
Start price
Target price
Perf. (%)
€50.00
23.05.21
23.05.21
€60.00
23.05.22
23.05.22
61.00%
24.05.22
24.05.22
Could be worthwhile Investment >10% per year
Boise Cascade Co
Start price
Target price
Perf. (%)
€52.00
18.05.21
18.05.21
€76.00
18.05.22
18.05.22
45.19%
19.05.22
19.05.22
Could be worthwhile Investment >10% per year
Fair valuation
Good rating
negative Cash Flow expected
Zosano Pharma Corp.
Start price
Target price
Perf. (%)
€1.43
02.05.22
02.05.22
€1.00
02.05.23
02.05.23
18.02%
05.05.22
05.05.22
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
Pra Group Inc
Start price
Target price
Perf. (%)
€31.20
01.05.21
01.05.21
€33.00
01.05.22
01.05.22
27.56%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.015
20.02.22
20.02.22
€7.50
20.03.22
20.03.22
61900.00%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€11.37
17.06.21
17.06.21
€18.00
09.03.22
09.03.22
95.60%
10.03.22
10.03.22
Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€28.67
07.03.22
07.03.22
€21.00
07.03.23
07.03.23
-33.73%
07.03.22
07.03.22
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€7.20
27.02.21
27.02.21
€12.00
27.02.22
27.02.22
109.58%
28.02.22
28.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
ROE higher than 10% per year
Growths much faster than the competition
Gtt Communications Inc
Start price
Target price
Perf. (%)
€1.56
27.02.21
27.02.21
€2.00
27.02.22
27.02.22
28.21%
28.02.22
28.02.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Capable Management
Small Risks for its business
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€13.13
21.02.22
21.02.22
€25.00
21.02.23
21.02.23
-7.07%
23.02.22
23.02.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Arcimoto Inc
Start price
Target price
Perf. (%)
€4.70
20.02.22
20.02.22
€6.00
20.02.23
20.02.23
0.43%
22.02.22
22.02.22
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Epizyme Inc.
Start price
Target price
Perf. (%)
€1.10
27.01.22
27.01.22
€1.00
27.01.23
27.01.23
41.00%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Ardelyx Inc.
Start price
Target price
Perf. (%)
€0.99
30.11.21
30.11.21
€1.00
30.11.22
30.11.22
36.36%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Greenhill & Co.inc.
Start price
Target price
Perf. (%)
€13.00
06.02.21
06.02.21
€15.00
06.02.22
06.02.22
20.00%
05.12.21
05.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Axonics Modulation Technologies Inc
Start price
Target price
Perf. (%)
€37.20
28.11.20
28.11.20
€42.00
28.11.21
28.11.21
31.72%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year